Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas

INTRODUCTION: Aggressive pituitary adenomas (APAs) are, by definition, resistant to optimal multimodality therapy. The challenge lies in their early recognition and timely management. Temozolomide is increasingly being used in patients with APAs, but evidence supporting a favorable response with ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Liza, Gupta, Nidhi, Dutta, Pinaki, Walia, Rama, Vaiphei, Kim, Rai, Ashutosh, Radotra, Bishan Dass, Gupta, Kirti, Sreedharanunni, Sreejesh, Ahuja, Chirag Kamal, Bhansali, Anil, Tripathi, Manjul, Sood, Ridhi, Dhandapani, Sivashanmugam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718901/
https://www.ncbi.nlm.nih.gov/pubmed/34975752
http://dx.doi.org/10.3389/fendo.2021.774686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718901/
https://www.ncbi.nlm.nih.gov/pubmed/34975752
http://dx.doi.org/10.3389/fendo.2021.774686

Ejemplares similares